Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Acq. announced
Panbela Therapeutics, Inc. (SNBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
07/19/2023 8-K Quarterly results
07/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: " "
06/16/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/02/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/31/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: " ",
" ",
" "
05/08/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/18/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/18/2023 8-K Quarterly results
03/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/16/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: " "
02/14/2023 SC 13G/A Cullen Michael T. reports a 3.3% stake in Panbela Therapeutics, Inc.
02/10/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/10/2023 8-K Quarterly results
01/31/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Regulation FD Disclosure, O...
Docs: " ",
" ",
" ",
" ",
" ",
" "
01/30/2023 SC 13G Lind Global Fund II LP reports a 9.9% stake in PANBELA THERAPEUTICS, INC.
01/30/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
01/26/2023 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
01/26/2023 EFFECT Form EFFECT - Notice of Effectiveness:
01/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: " "
01/18/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/17/2023 8-K Quarterly results
01/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/27/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
12/16/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
11/30/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
11/03/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy